Zymo Research’s DNA/RNA Shield™ inactivates monkeypox for sample transport

– Zymo Research’s DNA/RNA Shield™ inactivates monkeypox for sample collection and transport

IRVINE, Calif., July 15, 2022 /PRNewswire/ — Zymo Research Corp., in collaboration with the Institute of Virology at the University Medical Center Freiburg, Germany, has demonstrated data showing that its DNA/RNA Shield™ (ITM) inactivating transport medium completely inactivated recent monkeypox virus isolates.\

These data come at a critical time, as cases of monkeypox continue to rise worldwide and scientists search for methods to safely collect and transport samples without compromising genetic integrity. Screening for monkeypox is mainly done by PCR from a lesion taken with a swab.

The DNA/RNA Shield™ product line includes sample collection, storage and transport devices for samples used in infectious disease testing and research workflows. DNA/RNA Shield™ has enabled researchers to conduct infectious disease research and testing for the past decade, including during the COVID-19 pandemic.

Zymo Research offers several devices that can be filled with DNA/RNA Shield™, including the popular SafeCollect™ swab collection kit. SafeCollect™ Swab Collection Kits contain a collection swab and a patented tube with a tamper-evident seal to prevent accidental spillage, contact or ingestion of specimen stabilizing medium, making it ideal for specimen collection. home samples.

Learn more about Zymo Research’s SafeCollect™ DNA/RNA Shield Sample Collection Kits here.

Vea Datasheet.

About Zymo Research Corp.

Zymo Research is a privately held company serving the diagnostic and scientific community with state-of-the-art molecular biology tools since 1994. The company’s vision “The beauty of science is in keeping it simple” is reflected in all of its products, from epigenetics to DNA/RNA purification technologies. Historically recognized as a leader in epigenetics, Zymo Research is breaking boundaries with new solutions for sample collection, microbiome measurements, diagnostic devices, and next-generation sequencing (NGS) technologies that are high quality and easy to use. Follow Zymo Research on Facebook, LinkedIn, Twitter e instagram.

Photo – https://mma.prnewswire.com/media/1859786/Zymo_Research_Corp_ITM.jpgPhoto – https://mma.prnewswire.com/media/1859787/Zymo_Research_Corp_Assay.jpg

Leave a Comment